Hansa Biopharma AB (publ) (STO:HNSA)
29.70
-1.00 (-3.26%)
At close: Mar 6, 2026
Hansa Biopharma AB Employees
Hansa Biopharma AB had 125 employees as of December 31, 2025. The number of employees decreased by 10 or -7.41% compared to the previous year.
Employees
125
Change (1Y)
-10
Growth (1Y)
-7.41%
Revenue / Employee
1.78M SEK
Profits / Employee
-4.23M SEK
Market Cap
3.02B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Flerie AB | 9 |
| Vicore Pharma Holding AB | 36 |
| Saniona AB | 31 |
| Diamyd Medical AB | 41 |
| Egetis Therapeutics AB | 40 |
| BioInvent International AB | 109 |
| Genovis AB (publ.) | 36 |
| Xspray Pharma AB | 26 |
Hansa Biopharma AB News
- 3 days ago - PDUFA Action Date for Hansa Biopharma's Imlifidase BLA Set for December 19, 2026 - PRNewsWire
- 17 days ago - Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA - PRNewsWire
- 24 days ago - Hansa Biopharma AB (STU:24H) Q4 2025 Earnings Call Highlights: Robust Revenue Growth and ... - GuruFocus
- 24 days ago - Q4 2025 Hansa Biopharma AB Earnings Call Transcript - GuruFocus
- 24 days ago - Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results - PRNewsWire
- 6 weeks ago - Hansa Biopharma AB: Hansa Biopharma has won the 2025 SwedenBIO Award - Finanz Nachrichten
- 6 weeks ago - Hansa Biopharma has won the 2025 SwedenBIO Award - PRNewsWire
- 7 weeks ago - Hansa Biopharma AB at JPMorgan Healthcare Conference Transcript - GuruFocus